India to Saudi Arabia: Insulin Export Trade Route

The India to Saudi Arabia Insulin corridor is one of India's established pharmaceutical export routes, with 90 shipments documented worth a combined $2.3M USD. The route is dominated by MODERN DRUG HOUSE, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $25.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with insulin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 31.3%, placing it at rank #10 among India's top insulin export destinations globally.

On the import side, key buyers of Indian insulin in Saudi Arabia include TO THE ORDER OF-, `TO THE ORDER OF, TO THE ORDER OF and 5 others. TO THE ORDER OF- is the single largest importer with 31 shipments valued at $900.5K USD.

India's insulin exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. MODERN DRUG HOUSE with 39 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MODERN DRUG HOUSE, TIMES MEDICAMENT PRIVATE LIMITED, AMARI TRADE ALLIANCE LLP — together account for 94% of total trade value on this route. The average shipment value of $25.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical medicines for human use- 25% insulin lispro & 75% insulin lispro protamine suspension injection and pharmaceutical harmless medicines insulin lispro biphasic injection 25 insulinlispro and 75 insulin lispro inj 3ml p, suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF- is the largest importer with 31 shipments worth $900.5K USD — representing 39% of all insulin imports from India on this route. A total of 8 buyers are active on this corridor.